QuidelOrtho Corporation

LSE:0A55 Stock Report

Market Cap: US$2.4b

QuidelOrtho Future Growth

Future criteria checks 0/6

QuidelOrtho is forecast to grow earnings and revenue by 98.5% and 1.4% per annum respectively. EPS is expected to grow by 98.6% per annum. Return on equity is forecast to be 6.2% in 3 years.

Key information

98.5%

Earnings growth rate

98.6%

EPS growth rate

Medical Equipment earnings growth22.6%
Revenue growth rate1.4%
Future return on equity6.2%
Analyst coverage

Good

Last updated11 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0A55 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,899-24274726
12/31/20252,776-984234267
12/31/20242,763-1,896141247
9/29/20242,818-1,867-97100N/A
6/30/20242,835-1,859-17023N/A
3/31/20242,863-1,765-11991N/A
12/31/20232,998-1071280N/A
10/1/20233,12213147369N/A
7/2/20233,16245109318N/A
4/2/20233,110118389573N/A
1/1/20233,266549744885N/A
10/2/20223,0368109261,037N/A
7/3/20222,7621,0069361,124N/A
4/3/20222,3261,006484721N/A
1/2/20221,699704513806N/A
10/3/20211,871883634924N/A
7/4/20211,837900712917N/A
3/31/20211,8629481,0171,154N/A
1/3/20211,662810565630N/A
9/30/20201,005371194238N/A
6/30/2020655155152181N/A
3/31/202056288135163N/A
12/31/201953573107134N/A
9/30/201951575102130N/A
6/30/201950669117147N/A
3/31/201950165102133N/A
12/31/201852274105136N/A
9/30/20185053777104N/A
6/30/201843820N/A67N/A
3/31/201837312N/A34N/A
12/31/2017278-8N/A28N/A
9/30/2017216-5N/A33N/A
6/30/20172140N/A38N/A
3/31/20172154N/A49N/A
12/31/2016192-14N/A12N/A
9/30/2016189-12N/A11N/A
6/30/2016187-12N/A11N/A
3/31/2016183-14N/A-3N/A
12/31/2015194-6N/A37N/A
9/30/20152061N/A38N/A
6/30/2015201-4N/A42N/A
3/31/2015197-2N/A45N/A
12/31/2014184-7N/A36N/A
9/30/2014169-13N/A19N/A
6/30/2014160-12N/A14N/A
3/31/2014158-6N/A13N/A
12/31/20131777N/A26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0A55 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 0A55 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 0A55 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 0A55's revenue (1.4% per year) is forecast to grow slower than the UK market (3.6% per year).

High Growth Revenue: 0A55's revenue (1.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 0A55's Return on Equity is forecast to be low in 3 years time (6.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y